Title : NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.

Pub. Date : 2009 Jun

PMID : 19409854






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 INTERPRETATION: Oral methylprednisolone given in pulses every 4 weeks as an add-on therapy to subcutaneous interferon beta-1a in patients with relapsing-remitting multiple sclerosis leads to a significant reduction in relapse rate. Methylprednisolone interferon beta 1 Homo sapiens